Login / Signup

Response to Comment on de Carvalho et al. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors and Incident Type 2 Diabetes: A Systematic Review and Meta-analysis With Over 96,000 Patient-Years. Diabetes Care 2018;41:364-367.

Luiz Sérgio F de CarvalhoLuiz Sérgio Fernandes de CarvalhoAndrei Carvalho Sposito
Published in: Diabetes care (2018)
Keyphrases
  • low density lipoprotein
  • type diabetes
  • cardiovascular disease
  • case report
  • glycemic control
  • insulin resistance
  • metabolic syndrome
  • skeletal muscle